Efalizumab: a biological agent for the treatment of psoriasis.

Reviews on recent clinical trials

Volumn 1, Issue 2, 2006, Pages 165-168

  Hodulik, Sarah ^a   Hadi, Suhail ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EFALIZUMAB; IMMUNOLOGIC FACTOR; MONOCLONAL ANTIBODY;

CLINICAL TRIAL; DRUG EFFECT; HUMAN; PSORIASIS; REVIEW; T LYMPHOCYTE; TREATMENT OUTCOME;

ANTIBODIES, MONOCLONAL; CLINICAL TRIALS AS TOPIC; HUMANS; IMMUNOLOGIC FACTORS; PSORIASIS; T-LYMPHOCYTES; TREATMENT OUTCOME;

EID: 45549088591     PISSN: 15748871     EISSN: None     Source Type: Journal    
DOI: 10.2174/157488706776876436     Document Type: Review

References (25)